32% of firms lack social media plan

Share this article:
Two-thirds of life science company executives use social networking or plan to on behalf of their companies, a recent Deloitte survey said. Thirty-five percent said they have no plans to do so.
Around 44% said they have an informal strategy for social networking that is not documented or fully supported by leadership, and 32% have no strategy at all.
Many cited FDA's lack of clarity when asked what was holding them back. Thirty-eight percent said they're waiting for FDA guidance on social networking before making any investment, while 28% said they're waiting to see what return on investment other firms get.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.